S100A4 and breast carcinoma: Tumor-released S100A4 may stimulate stromal components such as osteoblast-lineage cells to mediate their interplay with osteoclasts, driving the microenvironment favorable for reactivation and growth of breast cancer cells in the bone-metastatic niche.